CAS 166547-20-2: 4H-1-Benzopyran-4-one,3-[2,4-dihydroxy-3-(3-methyl-2-buten-1-yl)phenyl]-7-hydroxy-

Eurycarpin A is a bioactive natural product, which is a secondary metabolite isolated from the medicinal plant species Eurycoma longifolia. This compound belongs to the class of quassinoids, known for their diverse therapeutic properties. Eurycarpin A exerts its mode of action through mechanisms that involve the inhibition of specific cellular pathways crucial for cancer cell proliferation and survival, including the modulation of apoptosis and interference with mitochondrial function. The uses and applications of Eurycarpin A are primarily focused on its potential as an anticancer agent. It is actively studied in the context of drug development and cancer research, where its efficacy against various cancer cell lines is evaluated. The compound's ability to induce cell cycle arrest and promote cancer cell death positions it as a promising candidate for therapeutic exploration. Furthermore, its natural derivation from Eurycoma longifolia provides an invaluable link to traditional medicine practices, serving as a bridge between ethnobotanical knowledge and modern pharmacological innovation. Research continues to delve into its full spectrum of biochemical interactions and potential therapeutic benefits.

Eurycarpin A is a natural product of Glycyrrhiza, Fabaceae.